DexCom, Inc. is a global company headquartered in San Diego, California, that focuses on the development, manufacturing, and distribution of continuous glucose monitoring (CGM) systems for managing diabetes. These systems enable individuals with diabetes to monitor their blood glucose levels consistently throughout the day, aiding in effective diabetes management and treatment decision-making. With a strong international presence, DexCom serves customers worldwide, contributing significantly to advancements in diabetes care through its innovative CGM technology.
When there are recessionary risks healthcare companies can remain profitable as consumers understandably prioritize health care. DexCom has some impressive seasonal patterns outlined which have been found using the Seasonax screener feature.
Over the last 15 years, DexCom has gained 14 out of 15 times. With a very strong seasonal pattern and excellent annualized returns of over 115% and an average of 13.18%, the main question is if it is worth looking at DexCom as we head into the summer months.
Major Trade Risks: The major trade risk here is for stock-specific news to DexCom or if the seasonal pattern fails to hold up this year.
HYCM clients can access the Seasonax product in order to analyze over 25,000 currency pairs, indices, commodities, as well as individual stocks. Please contact your account manager for a free trial. Certain products & services mentioned herein may or may not be available to all clients depending on which HYCM Capital Markets Group entity their trading account(s) adheres to.